|
|
||||||||
Departments of 1 Anesthesiology and 2 Surgery, University of Virginia, Charlottesville, Virginia 22906; and 3 Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, Michigan 48702
Pulmonary hypertension is
characterized by structural and morphological changes to the lung
vasculature. To determine the potential role of nitric oxide in the
vascular remodeling induced by hypoxia, we exposed wild-type
[WT(+/+)] and endothelial nitric oxide synthase (eNOS)-deficient
[(
/
)] mice to normoxia or hypoxia (10% O2) for 2, 4, and 6 days or for 3 wk. Smooth muscle
-actin and von Willebrand
factor immunohistochemistry revealed significantly less muscularization
of small vessels in hypoxic eNOS(
/
) mouse lungs than in WT(+/+)
mouse lungs at early time points, a finding that correlated with
decreases in proliferating vascular cells (5-bromo-2'-deoxyuridine
positive) at 4 and 6 days of hypoxia in the eNOS(
/
) mice. After 3 wk of hypoxia, both mouse types exhibited similar percentages of
muscularized small vessels; however, only the WT(+/+) mice exhibited an
increase in the percentage of fully muscularized vessels and increased
vessel wall thickness. eNOS protein expression was increased in hypoxic
WT(+/+) mouse lung homogenates at all time points examined, with
significantly increased percentages of small vessels expressing eNOS
protein after 3 wk. These results indicate that eNOS deficiency causes decreased muscularization of small pulmonary vessels in hypoxia, likely
attributable to the decrease in vascular cell proliferation observed in
these mice.
lung; hypertension; endothelial nitric oxide synthase; muscularization
This article has been cited by other articles:
![]() |
N. Weissmann, S. Hackemack, B. K. Dahal, S. S. Pullamsetti, R. Savai, M. Mittal, B. Fuchs, T. Medebach, R. Dumitrascu, M. v. Eickels, et al. The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L658 - L665. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Ghofrani, R. J. Barst, R. L. Benza, H. C. Champion, K. A. Fagan, F. Grimminger, M. Humbert, G. Simonneau, D. J. Stewart, C. Ventura, et al. Future perspectives for the treatment of pulmonary arterial hypertension. J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S108 - S117. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kimura, K. Egashira, L. Chen, K. Nakano, E. Iwata, M. Miyagawa, H. Tsujimoto, K. Hara, R. Morishita, K. Sueishi, et al. Nanoparticle-Mediated Delivery of Nuclear Factor {kappa}B Decoy Into Lungs Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension Hypertension, May 1, 2009; 53(5): 877 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Angelini, Q. Su, K. Yamaji-Kegan, C. Fan, J. T. Skinner, H. C. Champion, M. T. Crow, and R. A. Johns Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELM{alpha}) induces the vascular and hemodynamic changes of pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, April 1, 2009; 296(4): L582 - L593. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Wilkins, J. Wharton, F. Grimminger, and H. A. Ghofrani Phosphodiesterase inhibitors for the treatment of pulmonary hypertension Eur. Respir. J., July 1, 2008; 32(1): 198 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Coggins and K. D. Bloch Nitric Oxide in the Pulmonary Vasculature Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1877 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vermeersch, E. Buys, P. Pokreisz, G. Marsboom, F. Ichinose, P. Sips, M. Pellens, H. Gillijns, M. Swinnen, A. Graveline, et al. Soluble Guanylate Cyclase-{alpha}1 Deficiency Selectively Inhibits the Pulmonary Vasodilator Response to Nitric Oxide and Increases the Pulmonary Vascular Remodeling Response to Chronic Hypoxia Circulation, August 21, 2007; 116(8): 936 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Sehgal and S. Mukhopadhyay Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs? Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H77 - H85. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nadziejko, K. Fang, A. Bravo, and T. Gordon Susceptibility to pulmonary hypertension in inbred strains of mice exposed to cigarette smoke J Appl Physiol, May 1, 2007; 102(5): 1780 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Girgis, S. Mozammel, H. C. Champion, D. Li, X. Peng, L. Shimoda, R. M. Tuder, R. A. Johns, and P. M. Hassoun Regression of chronic hypoxic pulmonary hypertension by simvastatin Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1105 - L1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Stenmark, K. A. Fagan, and M. G. Frid Hypoxia-Induced Pulmonary Vascular Remodeling: Cellular and Molecular Mechanisms Circ. Res., September 29, 2006; 99(7): 675 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Frank, A. Abtahi, D.J. Yamaguchi, S. Manning, Y. Shyr, A. Pozzi, H. S. Baldwin, J. E. Johnson, and M. P. de Caestecker Bone Morphogenetic Protein 4 Promotes Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension Circ. Res., September 2, 2005; 97(5): 496 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. W.H. van der Heijden, Y. P.G. Essers, G. Fazzi, L. L.H. Peeters, J. G.R. De Mey, and G. J.J.M. van Eys Uterine Artery Remodeling and Reproductive Performance Are Impaired in Endothelial Nitric Oxide Synthase-Deficient Mice Biol Reprod, May 1, 2005; 72(5): 1161 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Kobs, N. E. Muvarak, J. C. Eickhoff, and N. C. Chesler Linked mechanical and biological aspects of remodeling in mouse pulmonary arteries with hypoxia-induced hypertension Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1209 - H1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Kallapur, C. J. Bachurski, T. D. L. Cras, S. N. Joshi, M. Ikegami, and A. H. Jobe Vascular changes after intra-amniotic endotoxin in preterm lamb lungs Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1178 - L1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Wagner, A.-K. Hellberg, S. Balenger, R. Depping, J. Dodd-O, R. A. Johns, and D. Li Hypoxia-Induced Mitogenic Factor Has Antiapoptotic Action and Is Upregulated in the Developing Lung: Coexpression with Hypoxia-Inducible Factor-2{alpha} Am. J. Respir. Cell Mol. Biol., September 1, 2004; 31(3): 276 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hasegawa, K. F. Wagner, D. Karp, D. Li, J. Shibata, M. Heringlake, L. Bahlmann, R. Depping, J. Fandrey, P. Schmucker, et al. Altered Pulmonary Vascular Reactivity in Mice with Excessive Erythrocytosis Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 829 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Tai, G. B. Robb, and P. A. Marsden Endothelial Nitric Oxide Synthase: A New Paradigm for Gene Regulation in the Injured Blood Vessel Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 405 - 412. [Abstract] [Full Text] |
||||
![]() |
X. Teng, D. Li, H. C. Champion, and R. A. Johns FIZZ1/RELM{alpha}, a Novel Hypoxia-Induced Mitogenic Factor in Lung With Vasoconstrictive and Angiogenic Properties Circ. Res., May 30, 2003; 92(10): 1065 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Paddenberg, B. Ishaq, A. Goldenberg, P. Faulhammer, F. Rose, N. Weissmann, R. C. Braun-Dullaeus, and W. Kummer Essential role of complex II of the respiratory chain in hypoxia-induced ROS generation in the pulmonary vasculature Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L710 - L719. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. NUNES, D. LEBREC, M. MAZMANIAN, F. CAPRON, J. HELLER, K. A. TAZI, E. ZERBIB, E. DULMET, R. MOREAU, A. T. DINH-XUAN, et al. Role of Nitric Oxide in Hepatopulmonary Syndrome in Cirrhotic Rats Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 879 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, V. E. Laubach, and R. A. Johns Upregulation of lung soluble guanylate cyclase during chronic hypoxia is prevented by deletion of eNOS Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L369 - L376. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Le Cras and I. F. McMurtry Nitric oxide production in the hypoxic lung Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L575 - L582. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Keegan, I. Morecroft, D. Smillie, M. N. Hicks, and M. R. MacLean Contribution of the 5-HT1B Receptor to Hypoxia-Induced Pulmonary Hypertension: Converging Evidence Using 5-HT1B-Receptor Knockout Mice and the 5-HT1B/1D-Receptor Antagonist GR127935 Circ. Res., December 7, 2001; 89(12): 1231 - 1239. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |